Literature DB >> 19195670

Mebendazole in parasitic infections other than those caused by soil-transmitted helminths.

R Cañete1, A A Escobedo, P Almirall, M E González, K Brito, S Cimerman.   

Abstract

Mebendazole, a benzimidazole carbamate compound, is currently in use for human medical practice against soil-transmitted helminthiasis (STH) and enterobiasis. However, it has been demonstrated that its spectrum of activity is broad and goes beyond those infections. Several studies provide evidence that this drug, taken at higher doses than used for STH and enterobiasis, could be sufficiently effective on some protozoa, nematodes and cestodes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19195670     DOI: 10.1016/j.trstmh.2008.11.029

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

1.  Increased Prevalence of Cestode Infection Associated with History of Deworming among Primary School Children in Ethiopia.

Authors:  Nader Mohamed; Anna Muse; Moges Wordofa; Dessie Abera; Abiyot Mesfin; Mistire Wolde; Kassu Desta; Aster Tsegaye; Bineyam Taye
Journal:  Am J Trop Med Hyg       Date:  2019-09       Impact factor: 2.345

2.  In vivo anthelmintic efficacy of Aloe ferox, Agave sisalana, and Gunnera perpensa in village chickens naturally infected with Heterakis gallinarum.

Authors:  Marizvikuru Mwale; Patrick Julius Masika
Journal:  Trop Anim Health Prod       Date:  2014-10-14       Impact factor: 1.559

3.  Mebendazole Is a Potential Alternative in the Treatment of Giardia duodenalis Infection.

Authors:  Roberto Cañete
Journal:  Curr Ther Res Clin Exp       Date:  2016-05-31

4.  Epidemiology of intestinal parasitic infections in school children in Ghazni Province, eastern Afghanistan.

Authors:  Krzysztof Korzeniewski; Alina Augustynowicz; Agata Smoleń; Anna Lass
Journal:  Pak J Med Sci       Date:  2015 Nov-Dec       Impact factor: 1.088

5.  Mebendazole reduces vascular smooth muscle cell proliferation and neointimal formation following vascular injury in mice.

Authors:  Jintao Wang; Hui Wang; Chiao Guo; Wei Luo; Alyssa Lawler; Aswin Reddy; Julia Wang; Eddy B Sun; Daniel T Eitzman
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

Review 6.  Drug repurposing and human parasitic protozoan diseases.

Authors:  Katherine T Andrews; Gillian Fisher; Tina S Skinner-Adams
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-03-24       Impact factor: 4.077

7.  Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model.

Authors:  Godfrey A Dzhivhuho; Samantha A Rehrl; Hlumani Ndlovu; William G C Horsnell; Frank Brombacher; Anna-Lise Williamson; Gerald K Chege
Journal:  PLoS Pathog       Date:  2018-07-26       Impact factor: 6.823

8.  Effectiveness and Tolerability of 3-Day Mebendazole Treatment of Giardia duodenalis Infection in Adults and Children: Two Prospective, Open-Label Phase IV Trials.

Authors:  Roberto Cañete; Katia Brito; Inara Brito; Abel Semper; Maria Elena Gonzalez
Journal:  Curr Ther Res Clin Exp       Date:  2018-11-30

9.  Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.

Authors:  Jong-Yil Chai; Bong-Kwang Jung; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2021-06-21       Impact factor: 1.341

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.